Table 1.
Author | Year | Study type | MHE/CHE diagnosis | Active treatment (s) | Patients treated | Weeks of treatment | Objectives | Main results |
Prasad et al[10] | 2007 | Original, randomized | NCT A, NCT B, FCT A, FCT B, PC, BDT | Lactulose | 45 (25) | 12 | Psychometry, QoL | Significant improvement in psychometry: P < 0001; and QoL: P < 0.002. Improvement in HRQoL was related to the improvement in psychometry. |
Sidhu et al[43] | 2011 | Original, randomized | NCT A, FCT A, Digit Symbol test, BDT, PC | Rifaximin | 94 (49) | 8 | MHE reversal, QoL | MHE reversal in 37/49 vs 9/45. Improvement in QoL. Improvement in HRQoL correlated with improvement in psychometry |
Sidhu et al[65] | 2016 | Original, randomized | NCT A, FCT A, Digit Symbol test, BDT, PC | Lactulose vs Rifaximin | 112 (55/57) | 12 | MHE reversal, QoL | MHE reversal in 38/55 and in 42/57; HRQoL was significantly improved in both groups |
Mittal et al[68] | 2011 | Original, randomized | NCT A, NCT B, FCT A, FCT B, PC, BDT | Lactulose or Probiotics or LOLA | 160 (40/40/40) | 12 | Psychometry, ammonia, QoL | MHE reversal in 19/40 vs 14/40 vs 14/40 vs 4/40. Improvement in QoL. |
Bajaj et al[72] | 2008 | Original, randomized | NCT A, Digit Symbol Test, BDT | Probiotic yogurt | 25 (17) | 8 | MHE reversal, OHE development, QoL, ammonia, cytokines | MHE reversal in 71% vs 0%; OHE development in 0% vs 25%; no differences in QoL and cytokine Levels. Excellent adherence in cirrhotics after probiotic yogurt supplementation with potential for long-term adherence |
Bajaj et al[81] | 2011 | Original, randomized | NCT A, NCT B, Digit Symbol test, BDT, ICT | Rifaximin | 42 (21) | 8 | Psychometry, QoL, driving ability, anti-inflammatory interleukins | Improvement in psychometry, driving performance and QoL |
Malaguarnera et al[76] | 2018 | Original, Observational | NCT-A, NCT-B, LTT, SDT, DST | Resveratrol | 35 (35) | Variable | QoL, ammonia levels | Resveratrol showed efficacy in the treatment of depression, anxiety, and ammonia serum levels, and improved the quality of life Of MHE patients. |
Malaguarnera et al[77] | 2011 | Randomized, double-blind, placebo-controlled study. | TMT-A, TMT-B | Acetyl-L-carnitine twice a day | 33 (34) | 13 | Clinical and laboratory assessments, psychometric tests and automated electroencephalogram (EEG) analysis and QoL evaluations | treatment is associated with significant improvement in patient energy levels, general functioning and well-being. The improvement of quality of life is associated with reduction of anxiety and depression. |
Zhang et al[82] | 2015 | Original | NCT A, NCT B, Digit Symbol test | Rifaximin | 26 (26) | 1 | Psychometry, ammonia, SIBO | MHE reversal in 15/26; reduction in SIBO and ammonia levels |
Bajaj et al[83] | 2014 | Original, randomized | NCT A NCT B, Digit Symbol test, BDT | Probiotics | 30 (14) | 8 | Psychometry, ammonia, inflammatory markers, QoL | Reduction in endotoxin and TNF-α but not in cytokines. No effects on psychometric performance |
Luo et al[84] | 2011 | Meta-analysis | Different diagnostic tools | Lactulose | 434 | Variable | Psychometry, ammonia levels, QoL, progression to OHE | Lactulose superior to placebo on all outcomes (psychometry: RR = 0.52, 95%CI: 0.44-0.62, P < 0.00001) |
MHE: Minimal hepatic encephalopathy; OHE: Overt hepatic encephalopathy: HRQoL: Health related quality of life; NCT-A: Number connection test-A; NCT-B: Number connection test-B; BDT: Block design test; SDT: Serial dotting test; DST: Digit symbol test; LTT: Line tracing test; PHES: Psychometric hepatic encephalopathy score; ICT: Inhibitory control test; CFF: Critical flicker frequency; EEG: Electroencephalogram; ICT: Inhibitory control test; BCAA; Branched chain amino acids; SIBO: Small intestine bacterial overgrowt; CEP: Cognitive evoked potentials; TNF: Tumor necrosis factor.